BioAge Labs, Inc. 2026 Annual Meeting of Stockholders

BioAge Labs, Inc. held its 2026 Annual Meeting of Stockholders on June 10, 2026. Stockholders approved the election of three Class II Directors: Patrick Enright, M.B.A., James I. Healy, M.D., Ph.D., and Rekha Hemrajani, M.B.A., each for a three-year term. The company also ratified the appointment of KPMG LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The report was signed by Dov Goldstein, Chief Financial Officer, on June 12, 2026.